USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023

USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023 The diagnosis and classification of hematopoietic tumors is increasingly complex and evolves rapidly.

• The introduction of the International Consensus Classification (ICC) of Myeloid and Lymphoid Neoplasms and publication of the proposed 5th edition World Health Organization (WHO) classification of the same tumors is the latest stage in this evolution and both further expand the clinical, morphologic, immunophenotypic and molecular genetic criteria for diagnosis.

 

• Join USCAP and learn from developers of the ICC on what is new in the classification of these tumors and how the ICC and proposed WHO compare. Leading clinical experts in hematology/oncology will also provide clinician perspectives on the importance of proper disease classification. The course will include disease specific lectures as well as opportunities to join experts in interactive microscopy sessions to gain practical knowledge on how to implement the new disease classifications into practice.

 

Videos+PDFs

Original release date: November 17, 2023

 

Small B-cell Neoplasms – Rebecca King, MD

• • Section: 1 Presentation 1 Document

Lymphoplasmacytic Lymphoma, Myeloma and Related Neoplasms – James Cook, MD, PhD

• • Section: 1 Presentation 1 Document

Cutaneous Lymphomas – John Goodlad, MD, MBChB, FRCPath

• • Section: 1 Presentation 1 Document

Clinician Perspective on the Diagnosis of B-cell Lymphoma – Jane Winter, MD

• • Section: 1 Presentation 1 Document

Aggressive B-cell Lymphomas – Elias Campo, MD, PhD

• • Section: 1 Presentation 1 Document

Hodgkin Lymphoma and Grey Zone Lymphomas – Elias Campo, MD, PhD

• • Section: 1 Presentation 1 Document

T-cell Lymphoma – Leticia Quintanilla-Fend, MD

• • Section: 2 Presentations 1 Document

Molecular Approach to Malignant Lymphoma – Laurence de Leval, MD, PhD

• • Section: 1 Presentation 1 Document

Clinician Perspective on the Diagnosis of T-cell Neoplasms – Steve Horwitz, MD

• • Section: 1 Presentation 1 Document

Immunodeficiency-associated Lymphoproliferative Disorders – Elaine Jaffe, MD

• • Section: 1 Presentation 1 Document

Histiocytic and Dendritic Cell Neoplasms – Elaine Jaffe, MD

• • Section: 1 Presentation 1 Document

Acute Lymphoblastic Leukemia/Lymphoma and Acute Leukemias of Ambiguous Lineage – Michael Borowitz, MD, PhD

• • Section: 1 Presentation 1 Document

Clonal Hematopoiesis and Myelodysplastic Syndromes – Robert Hasserjian, MD

• • Section: 1 Presentation 1 Document

Myeloproliferative Neoplasms – Hans-Michael Kvasnicka, MD, PhD

• • Section: 1 Presentation 1 Document

Mastocytosis – Attilio Orazi, MD, FRCPath

• • Section: 1 Presentation 1 Document

Clinician Perspective on the Diagnosis of Eosinophilic and Mast Cell Disorders – Ayalew Tefferi, MD

• • Section: 1 Presentation 1 Document

Myeloid/lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions – Sa Wang, MD

• • Section: 1 Presentation 1 Document

Myelodysplastic/myeloproliferative Neoplasms – Attilio Orazi, MD, FRCPath

• • Section: 1 Presentation 1 Document

Pediatric and/or Germline Disorders – Katherine Calvo, MD, PhD

• • Section: 1 Presentation 1 Document

Acute Myeloid Leukemia – Daniel Arber, MD

• • Section: 1 Presentation 1 Document

Clinician Perspective on the Diagnosis of Acute Myeloid Leukemia – Olatoyosi Odenike, MD

• • Section: 1 Presentation 1 Document

Molecular Approach to Myeloid Disorders – Adam Bagg, MD

• • Section: 1 Presentation 1 Document